Skip to content
Baret News – Lifestyle
Author:
Amneal Pharmaceuticals LLC
Amneal Reports Third Quarter 2026 Financial Results
November 3, 2026
Amneal to Report Third Quarter 2026 Results on November 3, 2026
October 8, 2026
Amneal Announces FDA Approval and Launch of Lanreotide Injection
September 18, 2026
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
August 10, 2026
Amneal Reports Second Quarter 2026 Financial Results
July 30, 2026
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
July 17, 2026
Amneal to Report Second Quarter 2026 Results on July 30, 2026
July 9, 2026
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
June 4, 2026
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 1, 2026